MWN Medical Minutes: August 3, 2022

Subcutaneous Atezolizumab Produces Non-Inferior Pharmacokinetics vs IV Atezolizumab in NSCLC | COVID-19: No Strong Local Response of The Conjunctival Immune System | CMS Proposed Minimum Staffing Requirements Could Cost $10B Annually